World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
34461
World Ranking
12551
National Ranking
390

Overview

Christian Roux is affiliated with Université Paris Cité in France and is an established researcher in the field of medicine with a specialization in rheumatology and bone health. Their research spans multiple subfields including Rheumatology, Orthopedics and Sports Medicine, Surgery, Pulmonary and Respiratory Medicine, and Oncology.

The scientist's work focuses primarily on topics related to bone health and osteoporosis research, rheumatoid arthritis research and therapies, parathyroid disorders and treatments, hip and femur fractures, spondyloarthritis studies and treatments, and bone and joint diseases. These themes are recurrent in their published studies and indicate a broad engagement with musculoskeletal disorders and metabolic bone conditions.

Christian Roux has contributed extensively to scientific literature with publications in various well-known venues. Frequent publication outlets include:

  • Revue du Rhumatisme
  • Annals of the Rheumatic Diseases
  • Joint Bone Spine
  • Osteoporosis International
  • The Journal of Clinical Endocrinology & Metabolism

Recent notable papers authored by Christian Roux include:

  • "Refracture and mortality following hospitalization for severe osteoporotic fractures: The Fractos Study" (2021) published in JBMR Plus
  • "The crisis of inadequate treatment in osteoporosis" (2020) published in The Lancet Rheumatology

The scientist frequently collaborates with other researchers. Prominent co-authors include Karine Briot, Thierry Thomas, Anna Moltó, Bernard Cortet, and S. Kolta, reflecting a strong network within the bone and joint research community.

Christian Roux's research encompasses 173 publications in Medicine with key contributions to Rheumatology (37 publications), Orthopedics and Sports Medicine (29 publications), and Surgery (21 publications). The emphasis on bone health and osteoporosis is supported by a significant number of works (40 publications), illustrating their expertise in these areas alongside associated conditions such as rheumatoid arthritis and parathyroid disorders.

Best Publications

  • Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

    Michael R. McClung;Piet Geusens;Paul D. Miller;Hartmut Zippel

  • Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis

    Jean-Yves Reginster;H. W. Minne;O. H. Sorensen;M. Hooper

  • 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

    Henry G Bone;Rachel B Wagman;Maria L Brandi;Jacques P Brown

  • Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis

    T. Schnitzer;H. G. Bone;G. Crepaldi;S. Adami

  • Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension

    Steven R Cummings;Serge Livio Ferrari;Richard Eastell;Nigel Gilchrist

  • Obesity is not protective against fracture in postmenopausal women: GLOW.

    Juliet E. Compston;Nelson B. Watts;Roland D. Chapurlat;Cyrus Cooper

  • Seven years of treatment with risedronate in women with postmenopausal osteoporosis.

    D. D. Mellström;O. H. Sörensen;S. Goemaere;C. Roux

  • Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.

    David M Reid;Jean-Pierre Devogelaer;Kenneth Saag;Christian Roux

  • Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density.

    Henry G Bone;Michael R McClung;Christian Roux;Robert R Recker

  • Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension.

    Socrates Papapoulos;Roland Chapurlat;Cesar Libanati;Maria Luisa Brandi

  • Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials

    Paul D Miller;Christian Roux;Steven Boonen;Ian P Barton

  • Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group.

    T Schnitzer;H G Bone;G Crepaldi;S Adami

  • Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS Study.

    Claus C Glüer;Richard Eastell;David M Reid;Dieter Felsenberg

  • Metabolic bone assessment in patients with inflammatory bowel disease

    Vered Abitbol;Christian Roux;Stanislas Chaussade;Serge Guillemant

  • The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension.

    Henry G. Bone;Roland D Chapurlat;Maria-Luisa Brandi;Jacques P Brown

  • Prevalence of rheumatoid arthritis in France: 2001

    F. Guillemin;A. Saraux;P. Guggenbuhl;C. H. Roux

  • The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study

    S Papapoulos;Kurt Lippuner;C Roux;C J F Lin

  • Prevalence of spondyloarthropathies in France: 2001

    A. Saraux;F. Guillemin;P. Guggenbuhl;C. H. Roux

  • Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk.

    E.L. Duncan;P. Danoy;J.P. Kemp;P.J. Leo

  • Impact of Prevalent Fractures on Quality of Life: Baseline Results From the Global Longitudinal Study of Osteoporosis in Women

    Jonathan D. Adachi;Silvano Adami;Stephen H. Gehlbach;Frederick A. Anderson Jr.

Frequent Co-Authors

Christine M. Albert
Christine M. Albert Cedars-Sinai Medical Center
Maxime Dougados
Maxime Dougados Hôpital Cochin
Jean-Yves Reginster
Jean-Yves Reginster University of Liège
Dimitris Visvikis
Dimitris Visvikis University of Western Brittany
Francis Guillemin
Francis Guillemin University of Lorraine
Mathieu Lamard
Mathieu Lamard University of Western Brittany
Bruno Fautrel
Bruno Fautrel Université Paris Cité
Ez-Zoubir Amri
Ez-Zoubir Amri Grenoble Alpes University
Gouenou Coatrieux
Gouenou Coatrieux IMT Atlantique
Jean-Pierre Devogelaer
Jean-Pierre Devogelaer Université Catholique de Louvain

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine offers many options beyond traditional MD programs. Many students and professionals are now turning to online degrees for flexibility and affordability. For nurses aiming to advance, pursuing the cheapest phd nursing programs can help you reach leadership or research roles while managing costs.

If you’re a registered nurse seeking to elevate your credentials, consider the most affordable accredited online rn to bsn programs. These programs are designed to be accessible and provide quality education to help you expand your opportunities.

For those without a nursing background, the quickest path to becoming an advanced practice nurse might be through direct entry msn programs. These options accept students from various fields and fast-track you into nursing with an advanced degree.

Additionally, some individuals prefer programs with less competitive admissions. There are several nursing schools with high acceptance rates, making it easier for aspirants to embark on a fulfilling healthcare career.

Best Scientists Citing Christian Roux

Trending Scientists